0

Ro 41-5253

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP144092319
CAS144092-31-9
Molecular Weight484.65
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

A Widely Used Retinoic Acid Receptor Antagonist Induces Peroxisome Proliferator-Activated Receptor-Gamma Activity

Michael Schupp, Joshua C Curtin, Roy J Kim, Andrew N Billin, Mitchell A Lazar

Mol Pharmacol. 2007 May;71(5):1251-7.

PMID: 17290005

1

RARalpha Antagonist Ro 41-5253 Inhibits Proliferation and Induces Apoptosis in Breast-Cancer Cell Lines

S Toma, L Isnardi, P Raffo, L Riccardi, G Dastoli, C Apfel, P LeMotte, W Bollag

Int J Cancer. 1998 Sep 25;78(1):86-94.

PMID: 9724098

1

Retinoic Acid Signaling Biomarkers After Treatment With Retinoic Acid and Retinoic Acid Receptor Alpha Antagonist (Ro 41-5253) in Canine Testis: An in Vitro Organ Culture Study

Vanmathy R Kasimanickam, Ramanathan K Kasimanickam

Theriogenology. 2013 Jan 1;79(1):10-6.

PMID: 23102850

1

Retinoids and Human Breast Cancer: In Vivo Effects of an Antagonist for RAR-alpha

Salvatore Toma, Laura Emionite, Angelo Scaramuccia, Giambattista Ravera, Linda Scarabelli

Cancer Lett. 2005 Feb 28;219(1):27-31.

PMID: 15694661

1

Retinoids and Malignant Melanoma: A Pathway of Proliferation Inhibition on SK MEL28 Cell Line

Laura Emionite, Fabia Galmozzi, Patrizia Raffo, Laura Vergani, Salvatore Toma

Anticancer Res. Jan-Feb 2003;23(1A):13-9.

PMID: 12680189

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode